Science
Mechanism of Action
This biomimetic peptide precisely emulates a specific ligand-binding segment of the Ectodysplasin A1 (EDA1) protein. Upon topical application, it directly interacts with the Ectodysplasin A receptor (EDAR), which plays a pivotal role in skin architecture. This interaction activates the WNT signaling pathway via NF-kB, initiating a cascade of cellular responses that promote anti-aging effects, including improved dermal elasticity, reduced wrinkle depth, enhanced skin hydration, and accelerated reparative processes.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
For optimal stability, SH-Oligopeptide-71 should be stored sealed and protected from light at temperatures between 2-8°C. For extended preservation, refrigeration at -15 to -20°C is highly recommended.
Safety
Safety Profile
The manufacturer indicates the absence of heavy metals and claims no skin or eye irritation. However, SH-Oligopeptide-71 currently lacks official review status from key regulatory bodies such as CIR, SCCS, or FDA, meaning comprehensive toxicological assessments are not publicly available.
Your Skin
Skin Compatibility
Our Assessment
Verdict
SH-Oligopeptide-71 presents a compelling biomimetic mechanism for diverse skin benefits; however, a current lack of documented clinical studies and official safety reviews indicates that more data is required for a conclusive efficacy and safety assessment.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources